(Q61914519)
Statements
bLAC - A Phase II Double-Blind, Placebo Controlled, Clinical Proof of Concept Trial of the Efficacy of 8 Weeks Treatment of Cutaneous Warts With bLAC in Immune Suppressed, Kidney Transplanted Patients (English)
0 references
March 2008
0 references
December 2008
0 references
120
0 references
18 year
0 references